Artenimol/Piperaquine Phosphate/Trimethoprim

双氢青蒿素/磷酸哌喹/甲氧苄啶

Report date: 2022/02/14 13:40:38

Base Information

Drug NameArtenimol/Piperaquine Phosphate/Trimethoprim
Drug Alias Name复方双氢青蒿素片Artekin安立康
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 3A4 inhibitorsDihydrofolate reductase inhibitors
TargetsCytochrome P450Cytochrome P450 3A4Dihydrofolate reductase
Therapy Area/IndicationsMalaria, VivaxMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes ArtenimolPiperaquine PhosphateTrimethoprim
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMalaria, VivaxMalaria, Falciparum
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A